Amarin Corp Plc (AMRN)

[MedResCollab]

Clinical hold coming?

In our view, an AdComm announcement for the efficacy supplement review is most likely between now and July 10, and is the most probable outcome here, for the reason that there are significant questions surrounding the efficacy of Vascepa.

We also would not at all be surprised to see a PR appear suddenly that the FDA has issued a clinical hold on the Evaporate trial, as its placebo group subjects are quite possibly being subjected to immediate and serious harm.